Year |
Citation |
Score |
2015 |
Iaea DB, Gale SE, Bielska AA, Krishnan K, Fujiwara H, Jiang H, Maxfield FR, Schlesinger PH, Covey DF, Schaffer JE, Ory DS. A novel intrinsically fluorescent probe for study of uptake and trafficking of 25-hydroxycholesterol. Journal of Lipid Research. PMID 26497473 DOI: 10.1194/Jlr.D064287 |
0.706 |
|
2014 |
Bielska AA, Olsen BN, Gale SE, Mydock-McGrane L, Krishnan K, Baker NA, Schlesinger PH, Covey DF, Ory DS. Side-chain oxysterols modulate cholesterol accessibility through membrane remodeling. Biochemistry. 53: 3042-51. PMID 24758724 DOI: 10.1021/Bi5000096 |
0.721 |
|
2013 |
Olsen BN, Bielska AA, Lee T, Daily MD, Covey DF, Schlesinger PH, Baker NA, Ory DS. The structural basis of cholesterol accessibility in membranes. Biophysical Journal. 105: 1838-47. PMID 24138860 DOI: 10.1016/J.Bpj.2013.08.042 |
0.732 |
|
2013 |
Olsen BN, Bielska A, Daily M, Schlesinger P, Baker N, Ory D. The Structural Basis of Cholesterol Activation in Membranes Biophysical Journal. 104: 662a. DOI: 10.1016/J.Bpj.2012.11.3657 |
0.723 |
|
2012 |
Bielska AA, Schlesinger P, Covey DF, Ory DS. Oxysterols as non-genomic regulators of cholesterol homeostasis. Trends in Endocrinology and Metabolism: Tem. 23: 99-106. PMID 22244444 DOI: 10.1016/J.Tem.2011.12.002 |
0.704 |
|
2011 |
Bielska AA, Ory DS, Covey DF. Synthesis of the enantiomer of the oxysterol-antagonist LY295427. Steroids. 76: 986-90. PMID 21470559 DOI: 10.1016/J.Steroids.2011.03.008 |
0.699 |
|
Low-probability matches (unlikely to be authored by this person) |
2009 |
Shen G, Fang H, Song Y, Bielska AA, Wang Z, Taylor JS. Phospholipid conjugate for intracellular delivery of peptide nucleic acids. Bioconjugate Chemistry. 20: 1729-36. PMID 19678628 DOI: 10.1021/Bc900048Y |
0.217 |
|
2019 |
Thompson CB, Bielska AA. Growth Factors Stimulate Anabolic Metabolism by Directing Nutrient Uptake. The Journal of Biological Chemistry. PMID 31628187 DOI: 10.1074/Jbc.Aw119.008146 |
0.161 |
|
2022 |
Bielska AA, Harrigan CF, Kyung YJ, Morris Q, Palm W, Thompson CB. Activating mTOR mutations are detrimental in nutrient-poor conditions. Cancer Research. PMID 35857801 DOI: 10.1158/0008-5472.CAN-22-0121 |
0.08 |
|
2019 |
Wu L, Reidy DL, Bielska A, Kelly V, Raj NP. Outcomes after cessation of therapy with alkylating agents (AA) for pancreatic neuroendocrine tumors (panNETs). Journal of Clinical Oncology. 37: 394-394. DOI: 10.1200/JCO.2019.37.4_suppl.394 |
0.061 |
|
2014 |
Brister MA, Pandey AK, Bielska AA, Zondlo NJ. OGlcNAcylation and phosphorylation have opposing structural effects in tau: phosphothreonine induces particular conformational order. Journal of the American Chemical Society. 136: 3803-16. PMID 24559475 DOI: 10.1021/Ja407156M |
0.045 |
|
2014 |
Brister MA, Pandey AK, Bielska AA, Zondlo NJ. OGlcNAcylation and phosphorylation have opposing structural effects in tau: Phosphothreonine induces particular conformational order Journal of the American Chemical Society. 136: 3803-3816. DOI: 10.1021/ja407156m |
0.04 |
|
2021 |
Bielska AA, Chatila WK, Walch H, Schultz N, Stadler ZK, Shia J, Reidy-Lagunes D, Yaeger R. Tumor Mutational Burden and Mismatch Repair Deficiency Discordance as a Mechanism of Immunotherapy Resistance. Journal of the National Comprehensive Cancer Network : Jnccn. 19: 130-133. PMID 33545685 DOI: 10.6004/jnccn.2020.7680 |
0.026 |
|
2006 |
Bielska AA, Zondlo NJ. Hyperphosphorylation of tau induces local polyproline II helix Biochemistry. 45: 5527-5537. PMID 16634634 DOI: 10.1021/Bi052662C |
0.016 |
|
Hide low-probability matches. |